| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MRVL | Common Stock | Options Exercise | $0 | +2,320 | +2% | $0 | 115,978 | 15 Apr 2023 | By Family Trust | F1 |
| transaction | MRVL | Common Stock | Tax liability | -$46,373 | -1,151 | -0.99% | $40.29 | 114,827 | 15 Apr 2023 | By Family Trust | F1, F2 |
| transaction | MRVL | Common Stock | Options Exercise | $0 | +1,384 | +1.2% | $0 | 116,211 | 15 Apr 2023 | By Family Trust | F1 |
| transaction | MRVL | Common Stock | Tax liability | -$27,679 | -687 | -0.59% | $40.29 | 115,524 | 15 Apr 2023 | By Family Trust | F1, F2 |
| transaction | MRVL | Common Stock | Options Exercise | $0 | +2,187 | +1.9% | $0 | 117,711 | 15 Apr 2023 | By Family Trust | F1 |
| transaction | MRVL | Common Stock | Tax liability | -$43,714 | -1,085 | -0.92% | $40.29 | 116,626 | 15 Apr 2023 | By Family Trust | F1, F2 |
| transaction | MRVL | Common Stock | Options Exercise | $0 | +1,367 | +1.2% | $0 | 117,993 | 15 Apr 2023 | By Family Trust | F1 |
| transaction | MRVL | Common Stock | Tax liability | -$27,316 | -678 | -0.57% | $40.29 | 117,315 | 15 Apr 2023 | By Family Trust | F1, F2 |
| transaction | MRVL | Common Stock | Options Exercise | $0 | +55,668 | +47% | $0 | 172,983 | 15 Apr 2023 | By Family Trust | F1 |
| transaction | MRVL | Common Stock | Tax liability | -$1,112,044 | -27,601 | -16% | $40.29 | 145,382 | 15 Apr 2023 | By Family Trust | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MRVL | Restricted Stock Units | Options Exercise | $0 | -2,320 | -100% | $0* | 0 | 15 Apr 2023 | Common Stock | 2,320 | Direct | F3, F4 | |
| transaction | MRVL | Restricted Stock Units | Options Exercise | $0 | -1,384 | -20% | $0 | 5,536 | 15 Apr 2023 | Common Stock | 1,384 | Direct | F3, F5 | |
| transaction | MRVL | Restricted Stock Units | Options Exercise | $0 | -2,187 | -11% | $0 | 17,496 | 15 Apr 2023 | Common Stock | 2,187 | Direct | F3, F6 | |
| transaction | MRVL | Restricted Stock Units | Options Exercise | $0 | -1,367 | -11% | $0 | 10,935 | 15 Apr 2023 | Common Stock | 1,367 | Direct | F3, F7 | |
| transaction | MRVL | Restricted Stock Units | Options Exercise | $0 | -55,668 | -100% | $0* | 0 | 15 Apr 2023 | Common Stock | 55,668 | Direct | F3, F8 | |
| transaction | MRVL | Restricted Stock Units | Award | $0 | +53,965 | $0 | 53,965 | 15 Apr 2023 | Common Stock | 53,965 | Direct | F3, F9 |
| Id | Content |
|---|---|
| F1 | Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust. |
| F2 | Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units ("RSUs"). |
| F3 | Each RSU represents a contingent right to receive one Marvell common share upon vesting. |
| F4 | This award fully vested on April 15, 2023. |
| F5 | The remaining RSUs will vest on 07/15/2023, 10/15/2023, 01/15/2024 and 04/15/2024. |
| F6 | The remaining RSUs will vest on 07/15/2023, 10/15/2023, 01/15/2024, 04/15/2024, 07/15/2024, 10/15/2024, 01/15/2025 and 04/15/2025. |
| F7 | The remaining RSUs will vest on 07/15/2023, 10/15/2023, 01/15/2024, 04/15/2024, 07/15/2024, 10/15/2024, 01/15/2025 and 04/15/2025. |
| F8 | This award is fully vested. Reflects the number of shares earned in respect of performance based RSUs granted on 04/15/2020. The achievement levels of the relative TSR performance metrics applicable to the award and the number of shares earned based on such results were certified on 04/14/2023. |
| F9 | The RSUs will vest in equal quarterly installments over three years, and were granted as part of the annual grant process. |